Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors.
about
Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cellsUpdate on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumorsHistone deacetylase inhibitors reduce polyglutamine toxicityLeukaemogenesis: more than mutant genesHistone deacetylase inhibitors: from target to clinical trials.Potential utility of natural products as regulators of breast cancer-associated aromatase promotersModified fatty acids and their possible therapeutic targets in malignant diseases.Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugsFK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors.Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?Emerging drugs for the treatment of myelodysplastic syndrome.Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents.Current clinical trials in amyotrophic lateral sclerosis.Identification and characterization of human MIBP1 gene in glioma cell differentiation.Sodium butyrate increases the effect of the photodynamic therapy: a mechanism that involves modulation of gene expression and differentiation in astrocytoma cells.Valproic acid: growth inhibition of head and neck cancer by induction of terminal differentiation and senescence.A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by phenylbutyrate on L1210 leukemic cells.Stereospecific regulation of tyrosine hydroxylase and proenkephalin genes by short-chain fatty acids in rat PC12 cells.FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.Identification of enzymes involved in oxidation of phenylbutyrate.Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humans.Phenylbutyrate inhibits the invasive properties of prostate and breast cancer cell lines in the sea urchin embryo basement membrane invasion assay.
P2860
Q28360372-3F3F772F-8C93-4D28-9E9E-E2D826434E43Q33385966-0A2FDBDB-F5DF-4D6E-AB43-A4FC9A1A1DD0Q33752772-7FB542A2-9F31-48A7-82B2-34C0DC74772CQ33953013-AF489B84-136A-484F-82AE-D61EB1217E45Q34275371-ACF2A362-1A32-4550-A950-77FE010BAFBFQ35011880-5F39FF67-E56E-4884-B565-6A016990587EQ35124690-1DDDC924-9C51-4D7A-8233-CD6A34A6E02BQ35537914-ECEEBCC1-0CC3-46E5-AB8C-CC3BE52F31E2Q35782919-D4956387-72CD-471C-B068-7F7ED64EAB3BQ35823157-56DE844D-FE4A-4672-A32F-3B94E9D14509Q35986327-46C74CFD-99D2-4495-8366-5945B4EFA076Q36179533-300204AF-EBA4-40F2-AE0E-DC03D84ACF70Q36219655-0A6AA110-A4D5-4FAD-9F14-0C23A5F226ECQ36321399-CFF5E68C-1FC2-4550-BD71-85A0A2097C0DQ36904850-87C793C0-8DD3-4BB5-A0E0-634B3F9F8245Q39070689-8D74E263-6CDC-4CC7-B01F-1D23671BDBEEQ39329059-30CEAEBA-07E6-4087-B960-55E55E429898Q39570650-67DF2E96-347B-4639-8AF0-C9C480780A56Q40348474-AAE778B7-61C7-4E82-8405-A25701522BB5Q40570608-DEF6C7FB-EBE6-4392-B4E7-765A271EE0CFQ40596470-CBF70CF2-AED2-4959-BEE4-53D657944FD6Q40612629-96E38528-CD7F-4D09-B029-0BDC0AFED82AQ42290254-1F448B54-7061-4090-9F08-0B9F7E824785Q44060683-944F9C2B-8F11-4536-A2A6-30B95A7FCA6DQ44128400-FADC140C-6694-4FBB-8A10-2EF3B8D14294
P2860
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Modifying histones to tame can ...... istone deacetylase inhibitors.
@ast
Modifying histones to tame can ...... istone deacetylase inhibitors.
@en
Modifying histones to tame can ...... istone deacetylase inhibitors.
@nl
type
label
Modifying histones to tame can ...... istone deacetylase inhibitors.
@ast
Modifying histones to tame can ...... istone deacetylase inhibitors.
@en
Modifying histones to tame can ...... istone deacetylase inhibitors.
@nl
prefLabel
Modifying histones to tame can ...... istone deacetylase inhibitors.
@ast
Modifying histones to tame can ...... istone deacetylase inhibitors.
@en
Modifying histones to tame can ...... istone deacetylase inhibitors.
@nl
P2860
P1476
Modifying histones to tame can ...... istone deacetylase inhibitors.
@en
P2093
P2860
P304
P356
10.1517/13543784.9.12.2923
P407
P577
2000-12-01T00:00:00Z